Catalytic Effect of Amyloid-β on Native Tau Aggregation at Physiologically Relevant Concentrations
Open Access
- 17 December 2025
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (24) , 12128
Abstract
Alzheimer’s disease (AD) is characterized by the accumulation and aggregation of tau and amyloid-β (Aβ). The pathophysiology and progression of AD are facilitated by the neurotoxic effects of these aggregated proteins, resulting in neurodegeneration and memory loss. In this context, the interaction between tau and Aβ42 is considered, but the mechanism underlying their pathogenic interplay remains unclear. Here, we addressed this question by studying the aggregation of full-length, unmodified tau and Aβ42 at physiologically low concentrations using atomic force microscopy (AFM). AFM imaging and data analyses demonstrate an increase in tau aggregation in the presence of Aβ42, characterized by increased sizes and number of aggregates. Importantly, tau aggregation occurs without the need for phosphorylation or any other post-translational changes. The analysis of the data demonstrates that tau and Aβ42 form co-aggregates, with no visible accumulation of Aβ42 aggregates alone. Given that the catalysis of tau aggregation by Aβ42 is observed at physiological low nanomolar concentrations of Aβ42, the finding suggests that such aggregation catalysis of tau by Aβ42 can be a molecular mechanism underlying the pathological tau aggregation process associated with the onset and development of Alzheimer’s disease.Keywords
All Related Versions
Funding Information
- NIH/NIGMS (R01GM148537)
This publication has 38 references indexed in Scilit:
- Tau Oligomer–Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer DiseaseJAMA Neurology, 2023
- Tau Fibrillation Induced by Heparin or a Lysophospholipid Show Different Initial Oligomer FormationJournal of Molecular Biology, 2023
- Cholesterol in Membranes Facilitates Aggregation of Amyloid β Protein at Physiologically Relevant ConcentrationsACS Chemical Neuroscience, 2021
- Hyperphosphorylation Renders Tau Prone to Aggregate and to Cause Cell DeathMolecular Neurobiology, 2020
- The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeuticsActa Neuropathologica, 2020
- Molecular Model for the Surface-Catalyzed Protein Self-AssemblyThe Journal of Physical Chemistry B, 2019
- Heterotypic seeding of Tau fibrillization by pre-aggregated Abeta provides potent seeds for prion-like seeding and propagation of Tau-pathology in vivoActa Neuropathologica, 2016
- Synergistic Interactions between Repeats in Tau Protein and Aβ Amyloids May Be Responsible for Accelerated Aggregation via Polymorphic StatesBiochemistry, 2011
- Mitochondrial dysfunction in sporadic and genetic Alzheimer's diseaseExperimental Gerontology, 2006
- A Novel Single-Molecule Study To Determine Protein−Protein Association ConstantsJournal of the American Chemical Society, 2001